You know what they say about bankruptcy, it’s a fresh start for those willing to take the leap. In this case, however, it is not the bankrupt company making a fresh start, it is a client. Global electric vehicle company Vmoto (ASX: VMT) is set to buy its UK Distributor, the UK Distribution—part of the
Read More
Are you tired of working hard for your money? Well, some cunning fraudsters in the US have found effortless ways to make quick cash – by counterfeiting winning pull-tab/instant lottery tickets. Employing a number of intricate methods, counterfeiters have adopted techniques such as barcode tampering, fake scratch-off coatings, and even using advanced printing techniques that
Read More
One of the world’s largest higher education sectors, India is home to over a thousand universities, 42k colleges, 11k standalone institutions and a college-age population—which is set to grow—that bolsters this system. India’s college-age population will reach 126 million by 2026. Even then, its higher education enrolment ratio lags behind China and Brazil. The Indian
Read More
As medical devices now have increased in demand for homecare, preventative treatments, and early diagnosis, it is no longer applicable strictly to the hospital diagnostic and treatment settings, but also other areas of healthcare such as health insurance. Thanks to this, medical imaging software and radiology company IMEXHS (ASX: IME) has secured another deal in
Read More
If its BNPL decline was not enough to usher IOUPay (ASX: IOU) in a different direction, its growing expenses into pushing buy-now-pay-later to no avail should. The Malaysian-based digital payments company lost share value and shareholder favor as the company experienced turmoil and witnessed resignations at the top. Its share price subsequently fell by 22.5%
Read More
Genetic eye problems affect over two million people worldwide and often lead to blindness among the working-age population. Though there’s a lot of optimistic research into potential treatments, none exists right now. That’s what the Western Australian biotech company PYC Therapeutics (ASX: PYC) is attempting to change. After successfully treating rabbits and monkeys suffering from
Read More